Global Diabetes Devices Market Analysis 2016-2026: Covering Sinocare, Sanofi & Novo Nordisk Among Others - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Feb 5, 2020--
The “Global Diabetes Devices Market Analysis 2019” report has been added to ResearchAndMarkets.com’s offering.
The Global Diabetes Devices market is expected to reach $44.66 billion by 2026 growing at a CAGR of 9.3% from 2018 to 2026.
Some of the factors such as rising awareness about therapeutics for diabetes & diabetes management among patients and the growing intensity of obesity and technological progressions are fuelling the market growth. However, rising advancement of non-invasive insulin delivery methods is restraining market growth.
Key Questions Answered in this Report:
Based on the type, monitoring devices segment has witnessed significant growth due to the rapid adoption of these user-friendly, quick, and accurate devices by patients for homecare use. Increasing awareness regarding diabetes, along with availability of a wide range of devices with fast and precise outcomes, is anticipated to fuel the segment.
Key Topics Covered:
1 Market Synopsis
2 Research Outline
2.1 Research Snapshot
2.2 Research Methodology
2.3 Research Sources
2.3.1 Primary Research Sources
2.3.2 Secondary Research Sources
3 Market Dynamics
4 Market Environment
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Diabetes Devices Market, By Type
5.2 Monitoring and Diagnostic Devices
5.3 Insulin Delivery Devices
6 Global Diabetes Devices Market, By Distribution Channels
6.2 Retail Pharmacies
6.3 Online Pharmacies
6.4 Hospital Pharmacies
6.5 Home Care
6.6 Diabetes Clinics/ Centers
6.7 Ambulatory Surgery Centers
6.8 Other Distribution Channels
7 Global Diabetes Devices Market, By Geography
7.2 North America
7.4 Asia Pacific
7.5 South America
7.6 Middle East & Africa
8 Strategic Benchmarking
9 Vendors Landscape
9.1 Sinocare, Inc.
9.3 Novo Nordisk
9.4 Medtronic PLC
9.5 Johnson & Johnson (LifeScan, Inc.)
9.6 F. Hoffmann-La Roche Ag
9.7 Eli Lilly and Company
9.8 DexCom Inc.
9.9 Bayer Corporation
9.10 Arkray, Inc.
9.11 Abbott Laboratories
For more information about this report visit https://www.researchandmarkets.com/r/timqw1
View source version on businesswire.com:https://www.businesswire.com/news/home/20200205005649/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: HEALTH DIABETES
SOURCE: Research and Markets
Copyright Business Wire 2020.
PUB: 02/05/2020 12:21 PM/DISC: 02/05/2020 12:21 PM